vs

Everus Construction Group, Inc.(ECG)与瑞思迈(RMD)财务数据对比。点击上方公司名可切换其他公司

瑞思迈的季度营收约是Everus Construction Group, Inc.的1.4倍($1.4B vs $1.0B),瑞思迈净利率更高(27.6% vs 5.5%,领先22.1%),Everus Construction Group, Inc.同比增速更快(33.2% vs 11.0%),过去两年Everus Construction Group, Inc.的营收复合增速更高(27.1% vs 7.9%)

瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业,主打可接入云端的呼吸类医疗设备,用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病,新冠疫情期间曾大量生产呼吸机等设备助力患者救治。

ECG vs RMD — 直观对比

营收规模更大
RMD
RMD
是对方的1.4倍
RMD
$1.4B
$1.0B
ECG
营收增速更快
ECG
ECG
高出22.2%
ECG
33.2%
11.0%
RMD
净利率更高
RMD
RMD
高出22.1%
RMD
27.6%
5.5%
ECG
两年增速更快
ECG
ECG
近两年复合增速
ECG
27.1%
7.9%
RMD

损益表 — Q4 FY2025 vs Q4 FY2026

指标
ECG
ECG
RMD
RMD
营收
$1.0B
$1.4B
净利润
$55.3M
$392.6M
毛利率
11.6%
61.8%
营业利润率
6.8%
34.6%
净利率
5.5%
27.6%
营收同比
33.2%
11.0%
净利润同比
60.4%
13.9%
每股收益(稀释后)
$1.09
$2.68

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
ECG
ECG
RMD
RMD
Q2 26
$1.4B
Q4 25
$1.0B
$1.4B
Q3 25
$986.8M
$1.3B
Q2 25
$921.5M
$1.3B
Q1 25
$826.6M
$1.3B
Q4 24
$759.6M
$1.3B
Q3 24
$761.0M
$1.2B
Q2 24
$703.4M
$1.2B
净利润
ECG
ECG
RMD
RMD
Q2 26
$392.6M
Q4 25
$55.3M
$392.6M
Q3 25
$57.0M
$348.5M
Q2 25
$52.8M
$379.7M
Q1 25
$36.7M
$365.0M
Q4 24
$34.5M
$344.6M
Q3 24
$41.8M
$311.4M
Q2 24
$39.0M
$292.2M
毛利率
ECG
ECG
RMD
RMD
Q2 26
61.8%
Q4 25
11.6%
61.8%
Q3 25
12.6%
61.5%
Q2 25
13.0%
60.8%
Q1 25
11.2%
59.3%
Q4 24
11.4%
58.6%
Q3 24
11.8%
58.6%
Q2 24
12.6%
58.5%
营业利润率
ECG
ECG
RMD
RMD
Q2 26
34.6%
Q4 25
6.8%
34.6%
Q3 25
7.3%
33.4%
Q2 25
7.9%
33.7%
Q1 25
6.2%
33.0%
Q4 24
6.1%
32.5%
Q3 24
7.1%
31.6%
Q2 24
7.3%
31.2%
净利率
ECG
ECG
RMD
RMD
Q2 26
27.6%
Q4 25
5.5%
27.6%
Q3 25
5.8%
26.1%
Q2 25
5.7%
28.2%
Q1 25
4.4%
28.3%
Q4 24
4.5%
26.9%
Q3 24
5.5%
25.4%
Q2 24
5.5%
23.9%
每股收益(稀释后)
ECG
ECG
RMD
RMD
Q2 26
$2.68
Q4 25
$1.09
$2.68
Q3 25
$1.11
$2.37
Q2 25
$1.03
$2.58
Q1 25
$0.72
$2.48
Q4 24
$0.68
$2.34
Q3 24
$0.82
$2.11
Q2 24
$0.76
$1.97

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
ECG
ECG
RMD
RMD
现金及短期投资手头流动性
$1.4B
总债务越低越好
$281.5M
$663.8M
股东权益账面价值
$629.8M
$6.3B
总资产
$1.7B
$8.5B
负债/权益比越低杠杆越低
0.45×
0.11×

8季度趋势,按日历期对齐

现金及短期投资
ECG
ECG
RMD
RMD
Q2 26
$1.4B
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$1.2B
Q1 25
$932.7M
Q4 24
$521.9M
Q3 24
$553.0K
$426.4M
Q2 24
$238.4M
总债务
ECG
ECG
RMD
RMD
Q2 26
$663.8M
Q4 25
$281.5M
$403.9M
Q3 25
$285.1M
$408.7M
Q2 25
$288.6M
$658.4M
Q1 25
$292.1M
$663.1M
Q4 24
$295.6M
$662.9M
Q3 24
$667.6M
Q2 24
$697.3M
股东权益
ECG
ECG
RMD
RMD
Q2 26
$6.3B
Q4 25
$629.8M
$6.3B
Q3 25
$573.0M
$6.1B
Q2 25
$514.4M
$6.0B
Q1 25
$460.2M
$5.5B
Q4 24
$422.6M
$5.3B
Q3 24
$453.3M
$5.2B
Q2 24
$490.0M
$4.9B
总资产
ECG
ECG
RMD
RMD
Q2 26
$8.5B
Q4 25
$1.7B
$8.5B
Q3 25
$1.6B
$8.3B
Q2 25
$1.5B
$8.2B
Q1 25
$1.4B
$7.6B
Q4 24
$1.3B
$7.1B
Q3 24
$1.3B
$7.2B
Q2 24
$6.9B
负债/权益比
ECG
ECG
RMD
RMD
Q2 26
0.11×
Q4 25
0.45×
0.06×
Q3 25
0.50×
0.07×
Q2 25
0.56×
0.11×
Q1 25
0.63×
0.12×
Q4 24
0.70×
0.13×
Q3 24
0.13×
Q2 24
0.14×

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
ECG
ECG
RMD
RMD
经营现金流最新季度
$48.2M
自由现金流经营现金流 - 资本支出
$23.5M
自由现金流率自由现金流/营收
2.3%
资本支出强度资本支出/营收
2.4%
现金转化率经营现金流/净利润
0.87×
过去12个月自由现金流最近4个季度
$90.0M

8季度趋势,按日历期对齐

经营现金流
ECG
ECG
RMD
RMD
Q2 26
Q4 25
$48.2M
$339.7M
Q3 25
$76.2M
$457.3M
Q2 25
$25.3M
$538.8M
Q1 25
$7.1M
$578.7M
Q4 24
$308.6M
Q3 24
$78.9M
$325.5M
Q2 24
$440.1M
自由现金流
ECG
ECG
RMD
RMD
Q2 26
Q4 25
$23.5M
$311.2M
Q3 25
$65.7M
$414.4M
Q2 25
$12.3M
$508.2M
Q1 25
$-11.4M
$557.9M
Q4 24
$288.0M
Q3 24
$60.9M
$307.7M
Q2 24
$415.2M
自由现金流率
ECG
ECG
RMD
RMD
Q2 26
Q4 25
2.3%
21.9%
Q3 25
6.7%
31.0%
Q2 25
1.3%
37.7%
Q1 25
-1.4%
43.2%
Q4 24
22.5%
Q3 24
8.0%
25.1%
Q2 24
33.9%
资本支出强度
ECG
ECG
RMD
RMD
Q2 26
Q4 25
2.4%
2.0%
Q3 25
1.1%
3.2%
Q2 25
1.4%
2.3%
Q1 25
2.2%
1.6%
Q4 24
1.6%
Q3 24
2.4%
1.5%
Q2 24
2.0%
现金转化率
ECG
ECG
RMD
RMD
Q2 26
Q4 25
0.87×
0.87×
Q3 25
1.34×
1.31×
Q2 25
0.48×
1.42×
Q1 25
0.19×
1.59×
Q4 24
0.90×
Q3 24
1.89×
1.05×
Q2 24
1.51×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

RMD
RMD

暂无分部数据

相关对比